Perrigo Names Head Of Regulatory Review

Article

Perrigo appoints Keith Webber as head of regulatory review.

Perrigo has appointed Keith Webber as head of regulatory review, effective Oct. 21, 2013 with responsibility for advancing the approval of all of Perrigo's consumer healthcare and prescription pharmaceutical regulatory applications pending with FDA, providing guidance on scientific and regulatory strategy for pipeline products, and advancing the quality of new regulatory applications.

Webber previously was Acting Director of the Office of the FDA's Pharmaceutical Science in the Center for Drug Evaluation and Research.

Source: Perrigo

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content